Pamela J. Cramer has sold RYTM and made no open-market buys since Aug 2022

Pamela J. Cramer is a human resources executive and corporate insider who serves as Chief Human Resources Officer (CHRO) at Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM).( She joined Rhythm in July 2021, bringing roughly 20 years of leadership experience in organizational effectiveness, talent development, and HR transformation across global life sciences and financial services companies.( As CHRO, she oversees human capital strategy and HR operations for the rare-disease biopharmaceutical company and participates in the company’s long‑term equity incentive programs, including grants of restricted stock units and stock options reported in recent SEC Form 4 filings.(

Before joining Rhythm, Cramer served as Head of People Solutions at Foundation Medicine, where she led HR delivery for more than 1,700 employees.( Her earlier career includes senior HR roles at Cambridge Associates, PAREXEL International, Epsilon Data Management, and positions at Bank of America Merrill Lynch, after beginning her career in General Electric’s Human Resources Leadership Program.( She holds an MBA from Georgetown University and has specialized in building scalable HR architectures, compensation planning, and talent development frameworks in growth-oriented and post‑acquisition environments.(

Written by Perplexity from public sources.